EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Identification of Compound Heterozygous EVC2 Gene Variants in Two Mexican Families with Ellis–van Creveld Syndrome

Nancy Negrete-Torres, María Del Carmen Chima-Galán, Ernesto Antonio Sierra-López, Janet Sánchez-Ramos, Isela Álvarez-González iD, Julia Reyes-Reali, María Isabel Mendoza-Ramos, Efraín Garrido-Guerrero, Dante Amato, Claudia Fabiola Méndez-Catalá iD, Glustein Pozo-Molina iD, Adolfo René Méndez-Cruz

Genes · 2023

DOI: 10.3390/genes14040887 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, 2023. Verfasst von Nancy Negrete-Torres und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Genética y Oncología Molecular, Laboratorio 5, Edificio A4, Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, Univ…. Hauptthemen laut MEDLINE: Membrane Proteins, Ellis-Van Creveld Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad Nacional Autonoma de Mexico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ellis–van Creveld syndrome (EvCS) is an autosomal recessive ciliopathy with a disproportionate short stature, polydactyly, dystrophic nails, oral defects, and cardiac anomalies. It is caused by pathogenic variants in the EVC or EVC2 genes. To obtain further insight into the genetics of EvCS, we identified the genetic defect for the EVC2 gene in two Mexican patients.

Methods

Two Mexican families were enrolled in this study. Exome sequencing was applied in the probands to screen potential genetic variant(s), and then Sanger sequencing was used to identify the variant in the parents. Finally, a prediction of the three-dimensional structure of the mutant proteins was made.

Results

One patient has a compound heterozygous EVC2 mutation: a novel heterozygous variant c.519_519 + 1delinsT inherited from her mother, and a heterozygous variant c.2161delC (p.L721fs) inherited from her father. The second patient has a previously reported compound heterozygous EVC2 mutation: nonsense mutation c.645G > A (p.W215*) in exon 5 inherited from her mother, and c.273dup (p.K92fs) in exon 2 inherited from her father. In both cases, the diagnostic was Ellis–van Creveld syndrome. Three-dimensional modeling of the EVC2 protein showed that truncated proteins are produced in both patients due to the generation of premature stop codons.

Conclusion

The identified novel heterozygous EVC2 variants, c.2161delC and c.519_519 + 1delinsT, were responsible for the Ellis–van Creveld syndrome in one of the Mexican patients. In the second Mexican patient, we identified a compound heterozygous variant, c.645G > A and c.273dup, responsible for EvCS. The findings in this study extend the EVC2 mutation spectrum and may provide new insights into the EVC2 causation and diagnosis with implications for genetic counseling and clinical management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsEllis-Van Creveld SyndromeHumansFemaleIntercellular Signaling Peptides and ProteinsPedigreeMutationCodon, Nonsense

Stichwörter der Autor:innen

EVC2 geneEllis–van Creveld syndromeMexican patientsciliopathieswhole exome sequencing

Substanzen

Membrane ProteinsIntercellular Signaling Peptides and ProteinsCodon, Nonsense

Autor:innen und Institutionen

  • Laboratorio de Genética y Oncología Molecular, Laboratorio 5, Edificio A4, Carrera de Médico Cirujano, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
  • Laboratorio de Genética, Escuela Nacional de Ciencias Biológicas Zacatenco, Instituto Politécnico Nacional, Ciudad de México 07738, Mexico.
  • Centro Médico Nacional "20 de Noviembre", ISSSTE, Ciudad de México 03229, Mexico.
  • Laboratorio de Inmunología, Unidad de Morfofisiología y Función, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.
  • Departamento de Genética y Biología Molecular, CINVESTAV-IPN, Ciudad de México 07360, Mexico.
  • División de Investigación y Posgrado, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla 54090, Mexico.

ORCID-Profile: Isela Álvarez-González, Claudia Fabiola Méndez-Catalá, Glustein Pozo-Molina

Förderung

  • Universidad Nacional Autonoma de Mexico

Zitieren

APA

Negrete-Torres, N., Chima-Galán, M. D. C., Sierra-López, E. A., Sánchez-Ramos, J., Álvarez-González, I., Reyes-Reali, J., Mendoza-Ramos, M. I., Garrido-Guerrero, E., Amato, D., Méndez-Catalá, C. F., Pozo-Molina, G., & Méndez-Cruz, A. R. (2023). Identification of Compound Heterozygous EVC2 Gene Variants in Two Mexican Families with Ellis–van Creveld Syndrome. Genes. https://doi.org/10.3390/genes14040887

Vancouver

Negrete-Torres N, Chima-Galán MDC, Sierra-López EA, Sánchez-Ramos J, Álvarez-González I, Reyes-Reali J, et al. Identification of Compound Heterozygous EVC2 Gene Variants in Two Mexican Families with Ellis–van Creveld Syndrome. Genes. 2023. doi:10.3390/genes14040887

BibTeX
@article{NegreteTorres2023,
  author = {Negrete-Torres, Nancy and Chima-Galán, María Del Carmen and Sierra-López, Ernesto Antonio and Sánchez-Ramos, Janet and Álvarez-González, Isela and Reyes-Reali, Julia and Mendoza-Ramos, María Isabel and Garrido-Guerrero, Efraín and Amato, Dante and Méndez-Catalá, Claudia Fabiola and Pozo-Molina, Glustein and Méndez-Cruz, Adolfo René},
  title = {Identification of Compound Heterozygous EVC2 Gene Variants in Two Mexican Families with Ellis–van Creveld Syndrome},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14040887}
}
Kostenlos starten →